NASDAQ: NVCRNovocure Ltd Stock Ownership - Who owns Novocure?
Insider buying vs selling
Have Novocure Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michal Nath Puri | Chief Human Resources Officer | 2025-06-30 | 833 | $15.13 | $12.60kBuy |
| Ashley Cordova | Chief Executive Officer | 2025-06-30 | 833 | $15.13 | $12.60kBuy |
| Frank X. Leonard | EVP Pres. Novocure Oncology | 2025-06-30 | 833 | $15.13 | $12.60kBuy |
| Asaf Danziger | Director | 2025-06-30 | 833 | $15.13 | $12.60kBuy |
| Arye Barak Ben | General Counsel | 2025-06-30 | 769 | $15.13 | $11.63kBuy |
| Gabriel Leung | Director | 2025-06-03 | 999 | $17.32 | $17.30kSell |
| Martin J. Madden | Director | 2025-06-03 | 999 | $17.19 | $17.18kSell |
| Allyson J. Ocean | Director | 2025-06-03 | 999 | $17.29 | $17.27kSell |
| Timothy J. Scannell | Director | 2025-06-03 | 999 | $17.32 | $17.30kSell |
| Jeryl L. Hilleman | Director | 2025-06-03 | 999 | $17.26 | $17.25kSell |
NVCR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NVCR insiders and whales buy or sell their stock.
NVCR Shareholders
What type of owners hold Novocure Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| William F. Doyle | 22.81% | 25,430,468 | $445.29M | Insider |
| Fmr LLC | 14.79% | 16,487,278 | $288.69M | Institution |
| Gert L. Perlhagen | 12.57% | 14,018,365 | $245.46M | Insider |
| Blackrock Inc | 11.69% | 13,027,792 | $228.12M | Institution |
| Vanguard Group Inc | 10.09% | 11,251,497 | $197.01M | Institution |
| Hansjoerg Wyss | 8.77% | 9,780,397 | $171.25M | Insider |
| Capital International Investors | 8.02% | 8,945,166 | $156.63M | Institution |
| Volati Ltd | 6.47% | 7,216,789 | $126.37M | Insider |
| Soleus Capital Management LP | 4.95% | 5,521,414 | $96.68M | Institution |
| Capital World Investors | 4.68% | 5,215,529 | $91.32M | Institution |
NVCR vs Medical Device Stocks
Novocure Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.